Severe Cardiovascular Depression with Remifentanil

Authors:
  • PEPeter Elliott
    Peter Elliott
  • RORonan O’hAre
    Ronan O’hAre
  • KBK. Moyna Bill
    K. Moyna Bill
  • APAnne S. Phillips
    Anne S. Phillips
  • FGFiona M. Gibson
    Fiona M. Gibson
  • RMRajinder K. Mirakhur
    Rajinder K. Mirakhur

Abstract
Atients had been enrolled (three received remifentanil at a rate of 1.0 μg · kg−1 · min−1, two at 0.33 μg · kg−1 · min−1, and three at 0.2 μg · kg−1 · min−1) because of severe hemodynamic instability, which was particularly marked in four patients and consisted of severe bradycardia in one patient and severe hypotension with a reduction in systemic vascular resistance in three others. One patient showed evidence of myocardial ischemia. All patients responded to therapeutic interventions. The results show that remifentanil should be given only by slow infusion to such patients. Implications This study investigates the effect on the heart and blood vessels of various rates of administration of boluses of a relatively new potent opiate, remifentanil, to patients with coronary artery disease. The results show that remifentanil should be given only by slow infusion to such patients....

This publication has 8 references indexed in Scilit: